SLDB

Solid Biosciences Inc.

9.43 USD
-0.02 (-0.21%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Solid Biosciences Inc. stock is up 16.71% since 30 days ago. The next earnings date is Mar 21, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 42.86% of the previous 6 February’s closed higher than January. In the last 1 Unusual Options Trades, there were 1 PUT.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
17 Jan 14:39 15 Mar, 2024 5.00 PUT 999 7

About Solid Biosciences Inc.

Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles.